Cesca Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Rancho Cordova CA United States (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
2017
NCT02538978
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

allogeneic adipose derived mesenchymal stem cell (1 trial)

Drugs in Phase 1 Trials (1)

Key: Cesca Therapeutics, Inc. (0) Acquired (1)

platelet rich plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ischemia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2